☆ 4.7 Article

Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice

BIOMEDICINE & PHARMACOTHERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Microbiology

Host Immunity and Immunization Strategies for Clostridioides difficile Infection

Farha Naz et al.

Summary: Clostridioides difficile infection (CDI) is a significant challenge to public health, designated as an urgent threat by the U.S. CDC. Recurrence is common in CDI patients, likely due to the use of antibiotics as primary treatment. This review summarizes the current understanding of the host's innate and adaptive immune responses to CDI, as well as other factors influencing the disease, such as C. difficile toxins and the host microbiota. It also discusses therapeutic approaches and the status of immunization strategies for CDI.

CLINICAL MICROBIOLOGY REVIEWS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Host Sorbitol and Bacterial Sorbitol Utilization Promote Clostridioides difficile Infection in Inflammatory Bowel Disease

Ziyu Yang et al.

Summary: Inflammatory bowel disease (IBD) is a globally increasing gastrointestinal inflammatory disorder. Patients with IBD have an increased risk of Clostridioides difficile infection (CDI), which worsens the clinical outcome of IBD. The underlying reasons for this are still poorly understood.

GASTROENTEROLOGY (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Global trends in gut microbiota and clostridioides difficile infection research: A visualized study

Zitong Li et al.

Summary: This study conducted a bibliometric analysis of publications on gut microbiota and CDI, finding that gut microbiota and CDI is likely to remain a prominent area of research in the foreseeable future. Current research hotspots include fecal microbiota transplantation, colonization resistance, and multidrug-resistant bacteria.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review

Peter H. R. Green et al.

Summary: This article summarizes the diagnosis and management of refractory celiac disease, providing guidance on evaluation, nutritional support, potential therapeutic options, and surveillance for complications. The article emphasizes the importance of regular follow-up and multidisciplinary care for patients with refractory celiac disease.

GASTROENTEROLOGY (2022)

添加到收藏夹

Article Infectious Diseases

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

Joffrey van Prehn et al.

Summary: The document provides guidance on the treatment of Clostridioides difficile infection with a focus on the best treatment methods and factors influencing treatment strategies.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

T. Kucharzik et al.

JOURNAL OF CROHNS & COLITIS (2021)

添加到收藏夹

Review Immunology

Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice

Stefano Bruscoli et al.

Summary: Inflammatory bowel disease (IBD) comprises ulcerative colitis (UC) and Crohn's disease (CD) and involves immune cell alteration and chronic inflammatory cascade activation against unknown environmental triggers. Therapy focuses on supporting measures and use of anti-inflammatory and immunosuppressive drugs, with glucocorticoids (GCs) being a cornerstone treatment for moderate-to-severe IBD. However, their use is limited by important adverse drug effects, leading researchers to explore newer, safer alternatives.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use

Travis J. Carlson et al.

Summary: The study demonstrated a 46% relative reduction in the odds of developing CDI in patients who received corticosteroids within the past 90 days. The results provide the best clinical evidence to further support mechanistic studies underlying this phenomenon.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Epidemiology of community-acquired and recurrent Clostridioides difficile infection

Yichun Fu et al.

Summary: Clostridioides difficile infection is a major issue in healthcare settings, with a rising incidence of community-associated infections. Patients with community-associated C. difficile tend to be younger with lower mortality rates. Although rates of recurrent C. difficile infection have decreased in the United States, further research and public health efforts are needed to address the changing epidemiology of this disease.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis

Marco Salice et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)

添加到收藏夹

Article Oncology

Budesonide treatment for microscopic colitis from immune checkpoint inhibitors

Michael S. Hughes et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

添加到收藏夹

Article Microbiology

Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice

N. J. Ajami et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease

Harminder Singh et al.

GASTROENTEROLOGY (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients

Tonya L. Scardina et al.

PHARMACOTHERAPY (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Management of inflammatory bowel disease with Clostridium difficile infection

Julie D'Aoust et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study

Akbar K. Waljee et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

添加到收藏夹

Article Medicine, General & Internal

Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study

Akbar K. Waljee et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

添加到收藏夹

Review Microbiology

The emerging metabolic view of Clostridium difficile pathogenesis

Andrew J. Hryckowian et al.

CURRENT OPINION IN MICROBIOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study

Roshan Razik et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease

Ting Zhang et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Review Medicine, General & Internal

Corticosteroid Therapy for Patients Hospitalized With Community Acquired Pneumonia A Systematic Review and Meta-analysis

Reed A. C. Siemieniuk et al.

ANNALS OF INTERNAL MEDICINE (2015)

添加到收藏夹

Article Microbiology

Corticosteroid use is associated with a reduced incidence of Clostridium difficile-associated diarrhea: A retrospective cohort study

Amy L. Wojciechowski et al.

ANAEROBE (2014)

添加到收藏夹

Article Microbiology

Fidaxomicin Inhibits Clostridium difficile Toxin A-Mediated Enteritis in the Mouse Ileum

Hon Wai Koon et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

The Systemic Inflammatory Response to Clostridium difficile Infection

Krishna Rao et al.

PLOS ONE (2014)

添加到收藏夹

Review Gastroenterology & Hepatology

Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

Christina M. Surawicz et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

添加到收藏夹

Review Medicine, General & Internal

Corticosteroids for acute bacterial meningitis

Matthijs C. Brouwer et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Practice of Gastroenterologists in Treating Flaring Inflammatory Bowel Disease Patients with Clostridium difficile: Antibiotics Alone or Combined Antibiotics/Immunomodulators?

Henit Yanai et al.

INFLAMMATORY BOWEL DISEASES (2011)

添加到收藏夹

Review Critical Care Medicine

Corticosteroids for severe sepsis: an evidence-based guide for physicians

Djillali Annane

ANNALS OF INTENSIVE CARE (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease

Chadwick Williams et al.

Therapeutic Advances in Gastroenterology (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Glucocorticoids Are Associated With Increased Risk of Short-Term Mortality in Hospitalized Patients With Clostridium difficile-Associated Disease

Rohit Das et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

添加到收藏夹

Article Gastroenterology & Hepatology

Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections

S. Schneeweiss et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)

添加到收藏夹

Review Medicine, General & Internal

MECHANISMS OF DISEASE Inflammatory Bowel Disease

Clara Abraham et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

Article Gastroenterology & Hepatology

A Mouse Model of Clostridium difficile-Associated Disease

Xinhua Chen et al.

GASTROENTEROLOGY (2008)

添加到收藏夹

Article Gastroenterology & Hepatology

5-Aminosalicylic Acid Inhibits Colitis-Associated Colorectal Dysplasias in the Mouse Model of Azoxymethane/Dextran Sulfate Sodium-Induced Colitis

Margie L. Clapper et al.

INFLAMMATORY BOWEL DISEASES (2008)

添加到收藏夹

Article Gastroenterology & Hepatology

Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand

Ho Kim et al.

GASTROENTEROLOGY (2007)

添加到收藏夹

Article Gastroenterology & Hepatology

Protease-activated receptor 2, dipeptidyl peptidase 1, and proteases mediate Clostridium difficile toxin A enteritis

Graeme S. Cottrell et al.

GASTROENTEROLOGY (2007)

添加到收藏夹

Article Microbiology

Rifalazil treats and prevents relapse of Clostridium difficile-associated diarrhea in hamsters

PM Anton et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)

添加到收藏夹

Article Multidisciplinary Sciences

Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation

PM Anton et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

添加到收藏夹

Article Pediatrics

Corticosteroid treatment of severe, non-responsive Clostridium difficile induced colitis

C Cavagnaro et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.